Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Operating Activities
Net income (loss)	$ 184,478	$ (113,435)
Adjustments to reconcile net income (loss) to operating activities:
Amortization, depreciation and write-offs	369,897	445,507
Stock-based compensation	275,058	143,943
Change in operating right-of-use asset	11,732	13,725
Amortization of debt issuance costs and discount	9,663	9,685
Loss on settlement of debt	4,337	0
Other	(3,906)	2,133
Changes in operating assets and liabilities, net of effect of acquisitions:
Accounts receivable	(146,796)	(139,350)
Prepaid expenses and other current assets	28,695	(70,242)
Other assets	(58,179)	(4,616)
Accounts payable	7,955	(7,881)
Operating lease liabilities	(12,253)	(15,345)
Accrued and other liabilities	32,416	(2,645)
Deferred revenue	14,425	(11,905)
Net cash provided by operating activities	717,522	249,574
Investing Activities
Acquisitions, net of cash acquired	(51,816)	(1,335,698)
Purchase of non-marketable equity securities	(16,934)	(56,546)
Capitalized software development costs	(6,523)	(4,546)
Purchase of property and equipment	(4,002)	(621)
Proceeds from sale of assets	8,250	3,657
Net cash used in investing activities	(71,025)	(1,393,754)
Financing Activities
Repurchases of stock	(1,153,593)	(338,880)
Principal repayments of debt	(490,494)	(17,482)
Payment of withholding taxes related to net share settlement	(115,846)	0
Payments of licensed asset obligation	(15,254)	(17,374)
Principal payments on finance leases	(16,191)	(18,099)
Payments of deferred acquisition costs	(11,503)	(104,998)
Payment of debt issuance cost	(4,545)	0
Proceeds from issuance of debt	210,281	0
Proceeds from revolving credit facility	185,000	0
Proceeds from exercise of stock options	17,807	21,733
Proceeds from the issuance of common stock under the Employee Stock Purchase Plan	2,071	3,663
Net cash used in financing activities	(1,392,267)	(471,437)
Effect of foreign exchange rate on cash and cash equivalents	(2,223)	(11,379)
Net decrease in cash and cash equivalents	(747,993)	(1,626,996)
Cash, cash equivalents and restricted cash equivalents at beginning of the period	1,080,484	2,570,504
Cash and cash equivalents at end of the period	332,491	943,508
Supplemental non-cash investing and financing activities disclosures:
Right-of-use assets acquired under finance leases	40,666	37,433
Right-of-use assets acquired under operating leases	4,576	3,400
Acquisitions not yet paid	0	40,791
Issuance of common stock in connection with acquisitions	0	137,422
Supplemental disclosure of cash flow information:
Cash paid for interest, net	184,600	107,650
Cash paid for income taxes, net of refunds	$ 12,749	$ 58,770